Julie FrentzelScientist at MerckSpeaker
Profile
Julie Frentzel completed her doctoral studies in oncology with a specialization in the field of Autophagy and non-coding RNAs at the Cancer Research Center of Toulouse, in 2016. Joining Merck KGaA in 2017, she became a scientist in the Cell Line Technologies team. Since then, her primary focus has been on advancing cell line development for biologics production and introducing innovative technologies to optimize traditional cell line development workflows.
Agenda Sessions
Enhancing Cell Line Development workflow efficiency using the Beacon
, 16:30View Session